• Ticker:- BBH;false;MVBBH;
  • Ticker Group:- ETFEQ_IND;false;;
  • How to Purchase

Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Biotech ETF BBH

  • Full Name: Market Vectors®
    Biotech ETF (BBH)

    Management Style: Replication

    Underlying Index: Market Vectors® US Listed Biotech 25 Index (MVBBHTR)

    Index Description: MVBBHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded biotech companies.

  •  
      

    • Fund Ticker

      BBH
    • Exchange

      NYSE Arca
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVBBHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 12/17/14

    • 30-Day SEC Yield1

      -0.17%
    • Total Net Assets

      $657.5M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.41%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Annual
    • Next Distribution Date

      12/19/2014
  • Portfolio Composition (%)
    as of 12/17/14

    • % of Net Assets
    • Stocks

      99.89
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      0.11
  • Download All HoldingsAll Holdings (%)as of 12/17/14

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Gilead Sciences Inc
    GILD US
    880,273
    90,139,95213.71
    Amgen Inc
    AMGN US
    487,868
    79,756,66412.13
    Celgene Corp
    CELG US
    609,348
    68,746,64010.46
    Biogen Idec Inc
    BIIB US
    153,687
    51,160,8647.78
    Alexion Pharmaceuticals Inc
    ALXN US
    182,140
    33,164,0525.04
    Vertex Pharmaceuticals Inc
    VRTX US
    286,618
    32,058,2244.88
    Regeneron Pharmaceuticals Inc
    REGN US
    76,632
    31,494,9864.79
    Incyte Corp Ltd
    INCY US
    378,408
    28,600,0764.35
    Illumina Inc
    ILMN US
    152,427
    27,621,2964.20
    Biomarin Pharmaceutical Inc
    BMRN US
    301,566
    26,299,5704.00
    Pharmacyclics Inc
    PCYC US
    175,064
    22,938,6363.49
    Medivation Inc
    MDVN US
    208,861
    22,268,7603.39
    Qiagen Nv
    QGEN US
    824,155
    18,972,0482.89
    Cubist Pharmaceuticals Inc
    CBST US
    182,107
    17,810,0642.71
    United Therapeutics Corp
    UTHR US
    119,253
    15,204,7582.31
    Isis Pharmaceuticals Inc
    ISIS US
    241,336
    13,871,9932.11
    Covance Inc
    CVD US
    131,481
    13,491,2652.05
    Alkermes Plc
    ALKS US
    229,940
    12,855,9451.96
    Puma Biotechnology Inc
    PBYI US
    55,805
    11,235,7791.71
    Nps Pharmaceuticals Inc
    NPSP US
    256,237
    9,250,1561.41
    Charles River Laboratories Internationa
    CRL US
    132,478
    8,330,2171.27
    Cepheid Inc
    CPHD US
    143,921
    7,165,8271.09
    Intercept Pharmaceuticals Inc
    ICPT US
    40,981
    5,766,4370.88
    Myriad Genetics Inc
    MYGN US
    137,740
    4,677,6510.71
    Seattle Genetics Inc
    SGEN US
    121,655
    3,909,9920.59
    Other/Cash
    696,6500.11
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.